Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
McKesson Corporation stock logo
MCK
McKesson
$734.93
-2.6%
$883.74
$637.00
$999.00
$92.45B0.35953,588 shs2.13 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$415.00
-1.4%
$396.79
$356.28
$555.45
$3.13T1.135.61 million shs33.25 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-3.1%
$27.14
$21.97
$28.75
$150.92B0.3536.09 million shs37.42 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
McKesson Corporation stock logo
MCK
McKesson
0.00%-7.58%-13.48%-20.52%+4.36%
Microsoft Corporation stock logo
MSFT
Microsoft
0.00%+3.22%+12.45%+4.93%-2.87%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-1.00%-3.62%-2.80%+16.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
McKesson Corporation stock logo
MCK
McKesson
$734.93
-2.6%
$883.74
$637.00
$999.00
$92.45B0.35953,588 shs2.13 million shs
Microsoft Corporation stock logo
MSFT
Microsoft
$415.00
-1.4%
$396.79
$356.28
$555.45
$3.13T1.135.61 million shs33.25 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-3.1%
$27.14
$21.97
$28.75
$150.92B0.3536.09 million shs37.42 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
McKesson Corporation stock logo
MCK
McKesson
0.00%-7.58%-13.48%-20.52%+4.36%
Microsoft Corporation stock logo
MSFT
Microsoft
0.00%+3.22%+12.45%+4.93%-2.87%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-1.00%-3.62%-2.80%+16.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
McKesson Corporation stock logo
MCK
McKesson
2.82
Moderate Buy$970.7332.09% Upside
Microsoft Corporation stock logo
MSFT
Microsoft
2.87
Moderate Buy$562.6935.59% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.7412.05% Upside

Current Analyst Ratings Breakdown

Latest MCK, PFE, and MSFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
McKesson Corporation stock logo
MCK
McKesson
Boost Price TargetBuy$1,000.00 ➝ $1,050.00
5/8/2026
McKesson Corporation stock logo
MCK
McKesson
Reiterated RatingBuy$875.00
5/8/2026
McKesson Corporation stock logo
MCK
McKesson
Lower Price TargetOverweight$1,107.00 ➝ $1,015.00
5/7/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Lower Price Target$678.00 ➝ $573.00
5/7/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Reiterated RatingBuy
5/6/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Boost Price TargetBuy$595.00 ➝ $680.00
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
DowngradeMarket Perform
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
UpgradeBuyHold
5/5/2026
Microsoft Corporation stock logo
MSFT
Microsoft
Boost Price TargetBuy$730.00 ➝ $870.00
5/4/2026
McKesson Corporation stock logo
MCK
McKesson
Reiterated RatingBuy (B+)
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
McKesson Corporation stock logo
MCK
McKesson
$403.43B0.22$37.84 per share19.42($13.52) per share-54.36
Microsoft Corporation stock logo
MSFT
Microsoft
$281.72B10.94$18.04 per share23.00$55.78 per share7.44
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.34$4.26 per share6.02$15.86 per share1.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
McKesson Corporation stock logo
MCK
McKesson
$3.30B$38.4719.1014.731.091.18%-378.75%5.83%N/A
Microsoft Corporation stock logo
MSFT
Microsoft
$101.83B$16.8024.7021.511.5239.34%31.94%18.47%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.588.97N/A11.83%19.44%8.41%N/A

Latest MCK, PFE, and MSFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q4 2026
McKesson Corporation stock logo
MCK
McKesson
$11.56$11.69+$0.13$13.71$101.35 billion$96.30 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
4/29/2026Q3 2026
Microsoft Corporation stock logo
MSFT
Microsoft
$4.06$4.27+$0.21$4.27$81.44 billion$82.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
McKesson Corporation stock logo
MCK
McKesson
$3.280.45%+11.16%8.53%17 Years
Microsoft Corporation stock logo
MSFT
Microsoft
$3.640.88%+10.24%21.67%23 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.71%-13.20%131.30%16 Years

Latest MCK, PFE, and MSFT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/21/2026
McKesson Corporation stock logo
MCK
McKesson
quarterly$0.820.4%6/1/20266/1/20267/1/2026
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
3/10/2026
Microsoft Corporation stock logo
MSFT
Microsoft
quarterly$0.910.9%5/21/20265/21/20266/11/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
McKesson Corporation stock logo
MCK
McKesson
N/A
0.88
0.48
Microsoft Corporation stock logo
MSFT
Microsoft
0.08
1.28
1.27
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.87

Institutional Ownership

CompanyInstitutional Ownership
McKesson Corporation stock logo
MCK
McKesson
85.07%
Microsoft Corporation stock logo
MSFT
Microsoft
71.13%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
McKesson Corporation stock logo
MCK
McKesson
0.08%
Microsoft Corporation stock logo
MSFT
Microsoft
0.03%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
McKesson Corporation stock logo
MCK
McKesson
45,000122.49 million122.39 millionOptionable
Microsoft Corporation stock logo
MSFT
Microsoft
228,0007.43 billion7.43 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer (PFE) Gets a Buy from Argus Research
Pfizer (NYSE:PFE) Stock Price Down 3.1% - Time to Sell?
GLP-1 battle heats up between Eli Lilly and Novo Nordisk
Pfizer (PFE) Receives a Buy from Scotiabank
Pfizer Sees Unusually High Options Volume (NYSE:PFE)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
McKesson stock logo

McKesson NYSE:MCK

$734.93 -19.83 (-2.63%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$736.85 +1.92 (+0.26%)
As of 05/8/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Microsoft stock logo

Microsoft NASDAQ:MSFT

$415.00 -5.77 (-1.37%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$415.12 +0.13 (+0.03%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

Pfizer stock logo

Pfizer NYSE:PFE

$25.65 -0.83 (-3.15%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$25.68 +0.03 (+0.11%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.